These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 26581123)
21. Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor. Baltos JA; Paoletta S; Nguyen AT; Gregory KJ; Tosh DK; Christopoulos A; Jacobson KA; May LT Mol Pharmacol; 2016 Jul; 90(1):12-22. PubMed ID: 27136943 [TBL] [Abstract][Full Text] [Related]
22. Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A Meibom D; Albrecht-Küpper B; Diedrichs N; Hübsch W; Kast R; Krämer T; Krenz U; Lerchen HG; Mittendorf J; Nell PG; Süssmeier F; Vakalopoulos A; Zimmermann K ChemMedChem; 2017 May; 12(10):728-737. PubMed ID: 28488817 [TBL] [Abstract][Full Text] [Related]
23. Structure-kinetics relationships of Capadenoson derivatives as adenosine A1 receptor agonists. Louvel J; Guo D; Soethoudt M; Mocking TA; Lenselink EB; Mulder-Krieger T; Heitman LH; IJzerman AP Eur J Med Chem; 2015 Aug; 101():681-91. PubMed ID: 26210506 [TBL] [Abstract][Full Text] [Related]
24. Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A Petrelli R; Scortichini M; Belardo C; Boccella S; Luongo L; Capone F; Kachler S; Vita P; Del Bello F; Maione S; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2018 Jan; 61(1):305-318. PubMed ID: 29257884 [TBL] [Abstract][Full Text] [Related]
25. Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity. Stewart GD; Valant C; Dowell SJ; Mijaljica D; Devenish RJ; Scammells PJ; Sexton PM; Christopoulos A J Pharmacol Exp Ther; 2009 Oct; 331(1):277-86. PubMed ID: 19641164 [TBL] [Abstract][Full Text] [Related]
26. Hetero-oligomerization between adenosine A₁ and thromboxane A₂ receptors and cellular signal transduction on stimulation with high and low concentrations of agonists for both receptors. Mizuno N; Suzuki T; Hirasawa N; Nakahata N Eur J Pharmacol; 2012 Feb; 677(1-3):5-14. PubMed ID: 22200626 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene. Romagnoli R; Baraldi PG; IJzerman AP; Massink A; Cruz-Lopez O; Lopez-Cara LC; Saponaro G; Preti D; Aghazadeh Tabrizi M; Baraldi S; Moorman AR; Vincenzi F; Borea PA; Varani K J Med Chem; 2014 Sep; 57(18):7673-86. PubMed ID: 25181013 [TBL] [Abstract][Full Text] [Related]
28. Activation of neuronal adenosine A1 receptors causes hypothermia through central and peripheral mechanisms. Province HS; Xiao C; Mogul AS; Sahoo A; Jacobson KA; Piñol RA; Gavrilova O; Reitman ML PLoS One; 2020; 15(12):e0243986. PubMed ID: 33326493 [TBL] [Abstract][Full Text] [Related]
30. Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts. Willems L; Reichelt ME; Molina JG; Sun CX; Chunn JL; Ashton KJ; Schnermann J; Blackburn MR; Headrick JP Cardiovasc Res; 2006 Jul; 71(1):79-87. PubMed ID: 16626672 [TBL] [Abstract][Full Text] [Related]
31. Biased Agonism of Endogenous Opioid Peptides at the μ-Opioid Receptor. Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M Mol Pharmacol; 2015 Aug; 88(2):335-46. PubMed ID: 26013541 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of adenosines with heterobicyclic and polycyclic N(6)-substituents as adenosine A(1) receptor agonists. Gosling JI; Baker SP; Haynes JM; Kassiou M; Pouton CW; Warfe L; White PJ; Scammells PJ ChemMedChem; 2012 Jul; 7(7):1191-201. PubMed ID: 22684887 [TBL] [Abstract][Full Text] [Related]
33. Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay. Saecker L; Häberlein H; Franken S Front Pharmacol; 2023; 14():1172551. PubMed ID: 37324481 [No Abstract] [Full Text] [Related]
34. Adenosine A₁ receptors do not play a major role in the regulation of lipogenic gene expression in hepatocytes. Yang M; Chu R; Chisholm JW; Doege H; Belardinelli L; Dhalla AK Eur J Pharmacol; 2012 May; 683(1-3):332-9. PubMed ID: 22449383 [TBL] [Abstract][Full Text] [Related]
35. [Stimulation of adenosine A1 receptor attenuates angiotensin II induced myocardial hypertrophy in neonatal rats via the extracellular signal-regulated kinase signal pathways]. Li ZY; Yang YH; Xing L Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Aug; 41(8):698-703. PubMed ID: 24225244 [TBL] [Abstract][Full Text] [Related]
36. Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activation. Cordeaux Y; Ijzerman AP; Hill SJ Br J Pharmacol; 2004 Nov; 143(6):705-14. PubMed ID: 15302686 [TBL] [Abstract][Full Text] [Related]
37. Biochemical and Pharmacological Role of A Varani K; Vincenzi F; Merighi S; Gessi S; Borea PA Adv Exp Med Biol; 2017; 1051():193-232. PubMed ID: 28676923 [TBL] [Abstract][Full Text] [Related]
38. Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding. Figler H; Olsson RA; Linden J Mol Pharmacol; 2003 Dec; 64(6):1557-64. PubMed ID: 14645687 [TBL] [Abstract][Full Text] [Related]
39. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists. Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637 [TBL] [Abstract][Full Text] [Related]
40. Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor. Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M Biochem Pharmacol; 2016 Aug; 113():70-87. PubMed ID: 27286929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]